Matt Fust

Matthew Fust is a board member and advisor for life sciences companies.

From 2009 - 2013, he was Chief Financial Officer of Onyx Pharmaceuticals. He previously served in Chief Financial Officer roles at Jazz Pharmaceuticals, Perlegen Sciences, and ALZA Corporation. Prior to joining ALZA, Matthew was a member of the healthcare strategy consulting practice at Andersen Consulting (now Accenture).

Matthew serves on the boards of Atara Biotherapeutics, Crinetics Pharmaceuticals, and Ultragenyx Pharmaceutical. He is also an advisor to Out Leadership/Quorum and Women In Bio.

Matthew holds an undergraduate degree in Accounting from the University of Minnesota and an MBA from the Stanford University Graduate School of Business.